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Surface expression of the K2P3.1 two-pore domain potas-
sium channel is regulated by phosphorylation-dependent
binding of 14-3-3, leading to suppression of coatomer coat
protein I (COPI)-mediated retention in endoplasmic reticu-
lum (ER). Here, we investigate the nature of the macromo-
lecular regulatory complexes that mediate forward and
retrograde transport. We demonstrate that (i) the channel
employs two separate but interacting COPI binding sites
on the N- and C-termini; (ii) disrupting COPI binding to
either site interferes with the ER retention; (iii) p11 and 14-
3-3 do not interact on their own; (iv) p11 binding to the C-
terminal retention motif is dependent on 14-3-3; and (v)
p11 is coexpressed in only a subset of tissues with K2P3.1,
while 14-3-3 expression is ubiquitous. We conclude that
K2P3.1 forward transport requires 14-3-3 suppression of
COPI binding, whereas p11 serves a modulatory role.
Key words: 14-3-3, annexin, background, COPI retention,
leak, p11, potassium channel, resting potential, TASK-1
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K2P3.1 channels pass background potassium currents that
stabilize cells at negative resting potentials and return cells
to baseline after excitatory events. The channels show
widespread tissue distribution, have a variety of natural
and medicinal regulators and have putative roles in re-
sponses to hormones, neurotransmitters, acidosis, oxy-
gen tension and local and volatile anesthetics (1–7). Quality
control mechanisms that ensure its controlled expression
on the plasma membrane are considered here.
K2P channel subunits have cytoplasmic N- and C-termini,
four transmembrane domains and two pore-forming
P loops, and two subunits appear both necessary and
sufficient to form an ion conduction pore (8–11). In 2002,
we observed that the K2P3.1 N-terminus has a dibasic
endoplasmic reticulum (ER) retrieval signal (KRQN) that
binds b coat protein (COP) to inhibit forward transport (12).
We demonstrated that phosphorylation-dependent bind-
ing of 14-3-3b, a cytoplasmic protein found in all cells (13),
suppressed b-COP binding and enabled forward transport
of the channel to the surface (12). Thus, two K2P3.1 chan-
nel populations were observed in vivo; one with b-COP and
no 14-3-3 and another with 14-3-3b and no b-COP. This
forward transport mechanism also appears to be exploited
by other proteins (12,14–16).
While we observed b-COP to bind on the K2P3.1
N-terminus and 14-3-3b to bind on the C-terminus, Girard
et al. found basic residues in the C-terminus that sup-
pressed channel expression and observed C-terminal bind-
ing of the annexin protein p11 (S100A10) in association
with forward transport (22). p11 has also been reported to
enhance plasma membrane expression of Nav1.8 sodium
channels (17), ASIC1a acid-sensing ion channels, transient
receptor potential cation channels (TRPV5 and 6) and se-
rotonin 1B receptor (18–20). In contrast, others found p11
to bind to the K2P3.1 C-terminus, leading to ER retention
through basic sites in p11 (21).
To examine these discordant observations regarding roles
of 14-3-3, COPI and p11 in regulation of K2P3.1 surface
expression, we sought to further delineate mechanistic
bases for their action. Here, we report that basic motifs
on both the N- and C-termini of K2P3.1 must be intact to
achieve ER retention. Both motifs can bind b-COP, and the
affinity of interaction is significantly reduced if either is
altered by mutation or 14-3-3b is bound to the channel
C-terminus. We find p11 in only some tissues that express
K2P3.1 (it is notably absent from heart) and show that p11
and 14-3-3 do not interact in the absence of the channel;
rather, p11 binds to K2P3.1 only after phosphorylation-
dependent binding of 14-3-3.
These observations argue that 14-3-3 is required to sup-
press COPI-dependent retention of K2P3.1 in ER and to
enable p11 modulation of channel forward transport in a
tissue-specific fashion.
Results
K2P3.1 has COPI binding motifs on both termini
The N-terminal K2P3.1 sequence MKRQN (but not the
mutant sequence MNQQN) plays a critical role in reten-
tion of the channel in the ER through COPI-mediated
retrograde transport because of binding of the coatomer
subunit b-COP (12). Girard et al. found K2P3.1 to be
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released from ER retention on mutation of residues in the
C-terminus (e.g. K389RRSSV to K389A or R390A or R391A)
(22). Altering these residues might suppress COPI binding
to the C-terminus and/or has the potential to suppress
phosphorylation of S393, which is required for 14-3-3
binding and ablation of COPI-dependent ER retention
through the N-terminus (12). We sought, therefore, to in-
vestigate if b-COP interacts with the K2P3.1 C-terminus. As
observed previously, peptides analogous to the N-terminus
bound b-COP when the dibasic motif was intact, similarly.
Indeed, peptides identical to the C-terminal 16 residues of
K2P3.1 (terminating -MKRRSSV) bound native b-COP from
COS-7 cells, whereas peptides with the basic residues
altered (-MNQQSSV) failed to bind (Figure 1A). These data
suggest that either the N- or C-terminal site alone might
yield channel retention through the COPI pathway, how-
ever, this is not the case; both sites must be intact to
achieve ER retention (12,22).
14-3-3 disrupts COPI binding on the C- but not the
N-terminus
As 14-3-3 binding suppresses b-COP binding to intact
K2P3.1 channels (12), we sought to study if 14-3-3 and
COPI competed for binding to the isolated N- or C-terminal
motifs. Semi-quantitative analysis showed comparable
amounts of b-COP bound to N- and C-terminal peptides
with a lower level isolated when the C-terminal peptide was
phosphorylated (Figure 1C). We hypothesized that the phos-
phopeptide bound 14-3-3 naturally present in the COS-7
cells interfered with b-COP association. To test this hypoth-
esis, the peptides were preincubated with recombinant
14-3-3b. Again, the N- and C-terminal peptides bound com-
parable amounts of b-COP, whereas binding to phosphor-
ylated C-terminal peptide was suppressed to undetectable
levels (Figure 1B,C). This demonstrated a direct role for
14-3-3 on the C-terminal motif not seen with the N-terminal
sequence.
Figure 1: b-COP interacts with both K2P3.1 N- and C-terminal motifs. A) Western blot analysis of native b-COP isolated from COS-7
cells on immobilized peptides analogous to the N- (MKRQNVA-) and C-termini (-MKRRSSV) of K2P3.1. Mutation of basic sites to
MNQQNVA- and -MNQQSSV results in failure to bind b-COP. Wild-type C-terminal peptide with phosphate (-MKRRSSPV) binds b-COP less
well because of binding of native 14-3-3 (12). B) Binding of recombinant 14-3-3b does not alter b-COP interaction with N-terminal or non-
phosphorylated C-terminal peptides but ablates binding to the phosphorylated K2P3.1 C-terminal peptide (-MKRRSS
PV). C) Bar chart shows
semi-quantitative analysis of b-COP binding to the indicated peptides before and after incubation with recombinant 14-3-3b through
computer-assisted densitometric scanning (IMAGE J software). Binding is presented as percentage of b-COP input based on total lysate
lane. D) HA-tagged wild-type (WT) and mutant K2P3.1 channels expressed in COS-7 cells purified by immunoprecipitation with HA
antibodies and analyzed by Western blot with antibodies to K2P3.1 (top) and b-COP (bottom) show WT channels affinity purified with
b-COP, while channels lacking either N- or C-terminal basic motifs fail to copurify b-COP. Ab, antibody; Ha, hemagglutinin epitope tag.
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N- and C-termini dibasic motifs are required in
intact channels
To confirm b-COP interaction with intact channels was
mediated through both the N- and C-termini, hemaggluti-
nin epitope-tagged K2P3.1 channels (HA-K2P3.1) were ex-
pressed in COS-7 cells and their association with native
b-COP evaluated. Figure 1D shows affinity purification
through the tag with wild-type (WT) and mutant K2P3.1
channels. Wild-type channels were purified in association
with b-COP. Channels mutated from KR to NQ in the
N-terminus (NQ-K2P3.1) or those altered from KRR to NQQ
in the C-terminus (K2P3.1-NQQSSV) were isolated without
b-COP (Figure 1D). Thus, mutation of either motif led to
the loss of b-COP binding to intact channels. This demon-
strates why each mutation alone could suppress ER
retention, reconciling prior reports (12,22).
Previously (12), we found that the channels without the
final channel residue (K2P3.1DV
395) failed to reach the
surface because of disruption of 14-3-3 binding but that
those also lacking their N-terminal basic site (NQ-
K2P3.1DV
395) did not bind b-COP and so gained surface
expression. Functional studies performed here in Xenopus
laevis oocytes demonstrate that K2P3.1DV
395 channels
also reach the surface to pass current if they lack the
retention motif from C-terminus (K2P3.1-NQQSSDV
395) or
both terminal motifs (NQ-K2P3.1-NQQSSDV
395), Figure 2
A. All channels reaching the surface demonstrated WT
selectivity based on reversal potential studies (not shown)
and inhibition by external acidification (Figure 2B) as found
for NQ-K2P3.1DV
395 channels before suggesting that traf-
ficking motifs do not alter biophysical function (12).
p11 binds to the C-terminus of K2P3.1 through 14-3-3
Both p11 and 14-3-3 have been implicated in enabling
forward transport of K2P3.1 through the same C-terminal
residues (22). We sought to define the basis for action of
p11 by testing the hypothesis that it binds to the channel in
a 14-3-3-dependent manner. Native 14-3-3 in COS-7 cells
binds to peptides homologous to the phosphorylated
C-terminus of K2P3.1 (-RRSS
PV), K2P9.1 (-RRKS
PV) and the
classical motif found in Raf1 protein (-RSASPEP) but fails to
bind to K2P3.1 peptide without the final valine (-RRSS
P) or
non-phosphorylated peptides Figure 3A). Native p11 in the
COS-7 cells showed an identical pattern of interaction with
the immobilized peptides, binding only in those cases
where 14-3-3 also bound (Figure 3B). In the absence of
native or recombinant 14-3-3b, recombinant p11 failed
to bind to any of the immobilized peptides (Figure 3C).
Conversely, recombinant 14-3-3b bound to peptides with
the same pattern observed for native 14-3-3 (Figure 3D)
and enabled interaction by recombinant p11 added sub-
sequently (Figure 3E).
p11 is only in some tissues
p11 protein was found in only a subset of tissues
examined (Figure 4A) in a manner consistent with its
previously reported messenger RNA distribution (23).
Figure 2: Retention motifs on both
termini must be intact to suppress
surface expression. A) Current–voltage
relationship for K2P3.1DV
395 (e), K2P3.1-
NQQSSDV395 (D), NQ-K2P3.1-NQQSSDV
395
u) and NQ-K2P3.1DV
395 (s) channels re-
corded by two-electrode voltage clamp in
oocytes depolarized from 135 to þ60 mV
in 15-mV increments from a holding poten-
tial of 80 mV (n ¼ 6). Inset shows repre-
sentative raw currents. B) Mean (SEM)
whole-cell currents evoked by repeated
step depolarizations from 80 to þ30 mV
at 10-second intervals, while bath solution
was exchanged from pH 7.5 (dark bar) to pH
6.5 (light bar; n ¼ 7–10 oocytes).
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Significantly, p11 was not seen in some tissues where
K2P3.1 and 14-3-3 were demonstrated (Figure 4B,C).
Ubiquitous distribution of 14-3-3 (13), the requirement
for phosphorylation-dependent binding of 14-3-3 to
achieve forward transport of WT K2P3.1 channels (12),
and patchy tissue distribution of p11 argue that its role in
trafficking is secondary.
p11 and 14-3-3 require K2P3.1 to interact
Native 14-3-3b can be isolated from rat brain (Figure 5A)
or human embryonic kidney (HEK 293) cell lysates that
express K2P3.1 (Figure 5B) on glutathione S-transferase
(GST)–p11 fusion protein immobilized on beads. Conversely,
GST–p11 beads do not isolate 14-3-3 from HEK 293 cells
that do not express K2P3.1 (Figure 5C) and do not bind pure
Figure 3: p11 fails to interact with
K2P3.1 in the absence of 14-3-3. A)
Western blot with anti-14-3-3 antibody
shows that native 14-3-3 from COS-7
cells binds to immobilized phosphopep-
tides homologous to WT K2P3.1 C-termi-
nus (-MKRRSSPV), K2P9.1 C-terminus
(-KRRKSPV) and Raf1 peptide (-RSASPEP).
Non-phosphorylated peptides and phos-
phorylated K2P3.1 peptide without the
final valine (-MRRSSP) fail to bind 14-3-3.
B) Antibody for p11 shows native p11 to
have an identical pattern of purification
as for 14-3-3 in panel A. C) Recombinant
p11 fails to interact with immobilized
K2P3.1 peptides in the absence of
14-3-3. D) Recombinant 14-3-3 binds like
native 14-3-3 from COS-7 cells in panel A.
E) Prior addition of recombinant 14-3-3
allows recombinant p11 to bind where it
had not before (panel C). Ab, antibody;
Recomb., recombinant.
Figure 4: Comparative tissue dis-
tribution of p11, 14-3-3b and
K2P3.1. A) Western blot analyses from
fresh tissue samples of p11 (top row),
14-3-3 (second row), K2P3.1 (third row)
and a-tubulin as a loading control
(bottom row). B) Semi-quantitative
evaluation of levels for each protein
through computer-assisted densito-
metric scanning (IMAGE J software).
Protein concentration was expressed
relative to a-tubulin concentration in
each tissue type studied. Ab, anti-
body; Panc., pancreas; Retic., rab-
bit reticulocyte; Sk. Mus, skeletal
muscle.
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recombinant 14-3-3b (Figure 5D). These findings indicate
that p11 and 14-3-3 do not interact on their own but require
the channel to form a ternary complex.
Discussion
Quality and quantity control mechanisms are in place to
ensure the emergence of correctly assembled membrane
proteins. Previously, we found that 14-3-3 binding allows
forward transport through inhibition of COPI binding to the
N-termini of K2P3.1 and K2P9.1 or the intracellular domain
of the immune molecule Iip35 (12). Here, we further
explore the mechanism of action of COPI and the basis
for binding of p11 to K2P3.1. We find that b-COP is capable
of binding to both the N- and C-terminal K2P3.1 sites in
isolation (Figure 1) but only assembles with the full chan-
nel when both sites are intact, and the C-terminus is free of
14-3-3 (Figure 2). The termini are therefore in direct
contact or interact in allosteric fashion. As bound 14-3-3
is a direct steric impediment to b-COP binding on the
C-terminus (the two sites overlap), 14-3-3 may also directly
mask the N-terminus of the folded channel complex.
p11 has been implicated in targeting of vesicles to cyto-
skeleton and membrane–vesicle fusion (24) and, recently,
in forward transport of an array of membrane proteins
(17–20). While Girard et al. (22) suggest p11 binds directly
to the C-terminus of K2P3.1 to enhance surface expres-
sion, we find here that purified p11 cannot bind in the
absence of added 14-3-3 (Figure 3). We submit that they
observed binding of p11 through unappreciated 14-3-3
endogenous to the yeast cells (25) and rabbit reticulocyte
lysates (Figure 4A). Here, purification of each protein and
reconstitution allowed direct demonstration that phos-
phorylation-dependent binding of 14-3-3 to the channel
C-terminus was required to enable subsequent association
of p11 (Figures 3 and 5). Ubiquitous expression of 14-3-3
and selective distribution of p11 support the idea that the
former plays a primary role in trafficking and the latter
serves as a modulator. This thesis is validated by obser-
vation of K2P3.1 in the heart, pancreas and skeletal muscle,
where little or no p11 protein is found (Figure 4). While we
suspect 14-3-3 will have a role with most proteins whose
targeting is modified by p11, Renigunta et al. (21) find p11
to bind in a 14-3-3-independent manner to a distinct motif
in K2P3.1 (not present in K2P9.1) that is approximately 100
residues upstream of the C-terminus; this indicates the
need for more study of the roles of p11 in trafficking.
Release from ER is achieved through masking of retention
signals (26,27) or powerful forward trafficking signals
(15,28). We have proposed 14-3-3 to have an important
role in forward transport through operation at sites that
suppress COPI binding to retention motifs. Previously, we
found the pathway to be phosphorylation dependent with
K2P3.1, K2P9.1, nAChR and Iip35 (12). Recent studies
extend the concept identifying 14-3-3 binding at release
sites that do not require phosphorylation (14). The growing
list of proteins recognized to require 14-3-3 to achieve
membrane expression and those subject to the modifying
influence of p11 reveals these trafficking regulators to be
of emerging importance.
Materials and Methods
Tissue preparation
Fresh tissue samples were collected from Wistar rats, washed in PBS,
weighed and diced. Further disruption and homogenization were performed
in ice-cold Buffer A (150 mM NaCl, 5 mM ethylenediaminetetraacetic acid
(EDTA), 1% Triton-X-100, 0.1% Na deoxycholate, 0.1% sodium dodecyl
sulfate (SDS) and 10 mM Tris–HCl pH 7.2) plus protease inhibitors and
incubated on ice for 30 min, followed by centrifugation to achieve whole
cell lysate or crude membrane factions. Protein concentration was deter-
mined by bicinchoninic acid protein assay reagent (Pierce). Samples were
diluted in 2 sample buffer, and 40 mg of each tissue sample was loaded
on SDS–PAGE for analysis.
Antibodies and Western blotting analysis
Purchased polyclonal (p) and monoclonal (m) antibodies used included
KCNK3 (p; Sigma-Aldrich), 14-3-3b (m, SC1657; Santa Cruz Biotechnology),
b-COP (p, PA1601; Affinity Bioreagent), hemagglutinin tag (m, 1583816;
Roche Molecular Biochemicals) and annexin II (light chain) clone LC148
(MP Biomedicals). SDS–PAGE (6, 12 or 18%) and Western blotting were
preformed by standard methods using enhanced chemiluminescence
(Pierce).
Figure 5: p11 and 14-3-3 only bind in the presence of K2P3.1.
Immobilized GST–p11 fusion protein isolates 14-3-3 from A) rat
brain lysate and B) HEK 293 cells expressing K2P3.1 but fails to
isolate 14-3-3 from C) naı¨ve HEK 293 cells and D) 10 mg added
recombinant 14-3-3. Immobilized GST control protein (GST) failed
to isolate 14-3-3 from all lysates tested. Ab, antibody; Recomb.
14-3-3, recombinant 14-3-3.
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Molecular biology and production of recombinant
protein
All K2P3.1 and 14-3-3 constructs were created as previously described (12).
Image clone #3889914 was subcloned in frame with GST into pGEX-6P-1
(Amersham Biosciences) between BamH1 and EcoR1 to create a GST
fusion of full-length p11. Cultures of Escherichia coli (BL21) were trans-
formed with pGEX recombinant vectors. Fusion proteins were purified and
coupled on Glutathione Sepharose 4B and released from the GST fusion
protein with PreScission protease according to the manufacturer’s protocol
(Amersham Biosciences). GST–p11 was also used in binding studies
following immobilization on Glutathione Sepharose 4B according to the
manufacturer’s instructions (Amersham Biosciences).
Peptide binding studies
All peptides and phosphopeptides were synthesized by the W.M. Keck
Biotechnology Resource Center (New Haven, CT, USA) and coupled to
Sulfolink Coupling Gel (Pierce) as previously described (12). COS-7 or HEK
293 whole cell lysate was prepared by solubilization of cells for 2 h at 48C in
150 mM NaCl, 5 mM EDTA, 1% Triton-X-100, 0.1% Na deoxycholate and
10 mM Tris–HCl pH 8.0 and centrifuged at 100 000  g for 30 min. The
resultant supernatant, recombinant p11 or 14-3-3 or rat brain post-nuclear
supernatant, was incubated with various immobilized peptides or GST
fusion proteins at 48C for 1 h. Unbound proteins were removed by three
washing steps with a cold PBS with 1% Triton-X-100, and bound proteins
were eluted with sample buffer for analysis by Western blotting.
Immunoprecipitation protocols
Affinity purification of HA-tagged K2P3.1 WT and channel mutants from
COS-7 cells was performed 24 h after transfection with Lipofectamine
(Invitrogen) by incubation for 1 h in immuno-precipitation (IP) buffer (50 mM
Tris, 100 mM NaCl and 1% Triton-X-100, pH 8.5) with 0.1% SDS and
centrifuged at 13 000  g for 20 min at 48C. Resultant supernatants were
immunoprecipitated with 5-mg HA monoclonal antibody or control IgG
overnight at 48C, purified on protein G–Sepharose gel (Amersham Bio-
sciences), washed with IP buffer, eluted by boiling in sample buffer and
loaded onto SDS–PAGE with 40 mg of lysate in control lane.
Electrophysiology
Oocytes were isolated from X. laevis frogs (Nasco), treated with collagenase
to ease removal of the follicular layer and injected with 0.1–1 ng of K2P3.1 WT
or mutant channel complementary RNA in 46 nL of sterile water. Currents
were measured 36–48 h after injection by two-electrode voltage clamp
(Warner Instruments Corp.). Data were filtered at 1 kHz and sampled at
4 kHz. Electrodes of 1.5-mm borosilicate glass tubes (Garner Glass Co.)
contained 3 M KCl and had resistances of 0.3–1 mOhm. Recordings were
performed at room temperature with perfusion of 0.4–1 mL/min ND96
(in mM) 93 NaCl, 5 KCl, 1 MgCl2, 0.3 CaCl2 and 5 HEPES, pH 7.5 or 6.5 with
NaOH or HCl. Holding potential was 80 mV. Currents were evoked by step
depolarization from 135 to þ60 mV in 15-mV increments. Acid sensitivity
was determined by exchanging external bath solutions during repeated step
depolarization from holding potential to þ30 mV at 10-second intervals.
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